PA
BPTH

Procyon Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Procyon Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-125
Closed -$13K – 1122
2020
Q2 		$13K Buy
125
+75
+150% +$7.78K 0.01% 616
2020
Q1 		$5K Hold
50
– – ﹤0.01% 742
2019
Q4 		$8K Buy
+50
New +$9.4K ﹤0.01% 722

Other funds holding BPTH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Human Investing Lake Oswego, Oregon $771M AUM 18.84% 1-Year Est. Return

Procyon Advisors's BPTH Position: Q3 2020 in Review

Procyon Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q3 2020, closing a stake of 125 shares — an estimated $13K sold.

Procyon Advisors first reported a position in BPTH in Q4 2019 and held it in 3 quarters. The position peaked at $13K in Q2 2020. 14 funds tracked by Wall St. Rank hold BPTH as of Q3 2020.

  • Procyon Advisors reported no remaining Bio-Path Holdings Inc position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 125 Bio-Path Holdings Inc shares in Q3 2020, an estimated $13K.
  • Procyon Advisors first reported a position in Bio-Path Holdings Inc in Q4 2019 and held it in 3 quarters.
  • Procyon Advisors's Bio-Path Holdings Inc position peaked at $13K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.